Ligand Pharmaceuticals News

Ligand Pharmaceuticals Analyst Ratings

BenzingaApr 12 09:12 ET

Ligand Pharmaceuticals Analyst Ratings

BenzingaFeb 29 15:38 ET

Benchmark Reiterates Buy on Ligand Pharmaceuticals, Maintains $95 Price Target

BenzingaDec 13, 2023 10:47 ET

Ligand Pharmaceuticals Analyst Ratings

BenzingaDec 13, 2023 10:46 ET

HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $144 Price Target

BenzingaSep 19, 2023 12:01 ET

Ligand Pharmaceuticals Analyst Ratings

BenzingaSep 19, 2023 12:00 ET

Benchmark Reiterates Buy on Ligand Pharmaceuticals, Maintains $95 Price Target

BenzingaAug 23, 2023 10:02 ET

Ligand Pharmaceuticals Analyst Ratings

BenzingaAug 23, 2023 10:00 ET

HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $144 Price Target

BenzingaAug 9, 2023 06:37 ET

Ligand Pharmaceuticals Analyst Ratings

BenzingaAug 9, 2023 06:37 ET

Barclays Cuts Price Target on Ligand Pharmaceuticals to $110 From $120, Maintains Overweight Rating

MT NewswiresJul 25, 2023 09:47 ET

Barclays Maintains Overweight on Ligand Pharmaceuticals, Lowers Price Target to $110

BenzingaJul 25, 2023 06:59 ET

Ligand Pharmaceuticals Analyst Ratings

BenzingaJul 25, 2023 06:57 ET

HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Raises Price Target to $144

BenzingaJun 2, 2023 09:48 ET

Ligand Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsFeb 21, 2023 09:18 ET

Benchmark Reiterates Buy on Ligand Pharmaceuticals, Maintains $95 Price Target

Benzinga Real-time NewsFeb 21, 2023 08:44 ET

Tesla To $175? Here Are 10 Other Price Target Changes For Friday

Benzinga Real-time NewsDec 23, 2022 09:22 ET

Ligand Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsDec 23, 2022 07:44 ET

Roth Capital Maintains Buy on Ligand Pharmaceuticals, Raises Price Target to $90

Benzinga Real-time NewsDec 23, 2022 07:44 ET

Ligand Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsNov 21, 2022 07:32 ET